Novartis AG (NYSE:NVS)
| 97.88 Delayed Data As of Nov 30 |  +0.87 / +0.90%Today’s Change | 75.68 Today|||52-Week Range 99.94 | +14.02% Year-to-Date |
Latest NVS News | Press Releases
| Why Is Pfizer (PFE) Down 1.4% Since Last Earnings Report? Nov 30 / Zacks.com - Paid Partner Content | Olema Pharmaceuticals (OLMA) Skyrockets 471% YTD: Here's Why Nov 27 / Zacks.com - Paid Partner Content |
| CAR T-Cell Therapies Under FDA Watch on Reports of Malignancies Nov 29 / Zacks.com - Paid Partner Content | Mesoblast (MESO) Up on Deal With BMT CTN to Develop GVHD Drug Nov 23 / Zacks.com - Paid Partner Content |
| Novartis (NVS) Raises Mid-Term Sales Outlook; Outlines Strategy Nov 28 / Zacks.com - Paid Partner Content | The Zacks Analyst Blog Highlights Procter & Gamble, Novartis, Mondelez International, Elevance Health and Vertex Pharmaceuticals Nov 21 / Zacks.com - Paid Partner Content |
| 3 Large Drug Stocks That Have Outperformed Industry YTD Nov 28 / Zacks.com - Paid Partner Content | Top Stock Reports for Procter & Gamble, Novartis & Mondelez International Nov 20 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 97.01 |
| Today’s open | 96.87 |
| Day’s range | 96.73 - 97.91 |
| Volume | 1,099,539 |
| Average volume (3 months) | 1,319,129 |
| Market cap | $201.7B |
Data as of 4:00pm ET, 11/30/2023
Growth & Valuation
| Earnings growth (last year) | -70.23% |
| Earnings growth (this year) | +17.64% |
| Earnings growth (next 5 years) | +11.08% |
| Revenue growth (last year) | -2.09% |
| P/E ratio | 25.4 |
| Price/Sales | 3.94 |
| Price/Book | 3.51 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | +0.44 | +0.69% |
| PFEPfizer | +0.36 | +1.20% |
| ABBVAbbVie | +3.86 | +2.79% |
| MRKMerck | +1.32 | +1.31% |
Data as of 4:00pm ET, 11/30/2023
Financials
| Next reporting date | January 31, 2024 |
| EPS forecast (this quarter) | $1.67 |
| Annual revenue (last year) | $50.5B |
| Annual profit (last year) | $7.0B |
| Net profit margin | 13.76% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Basel, Basel-stadt (basle Town) |
Forecasts
